Dual antiplatelet therapy beyond 12 months versus for 12 months after drug-eluting stents for acute myocardial infarction
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q1
- 저널
- JOURNAL OF CARDIOLOGY75(1) · pp.66 · 2020
- 피인용
- Web of Science 9Scopus 11
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 2.246
- ISSN
- 0914-5087
저자
- Sim, Doo Sun제1저자Chonnam National University Hospital, Gwanjgu, Republic of Korea
- Jeong, Myung Ho교신저자Chonnam National University Hospital, Gwanjgu, Republic of Korea
- Kim, Hyo SooSeoul National University Hospital, Seoul, Republic of Korea
- Gwon, Hyeon CheolSungkyunkwan University, Seoul Samsung Medical Center, Seoul, Republic of Korea
- Seung, Ki BaeThe Catholic University of Korea, Seoul, Republic of Korea
- Rha, Seung WoonKorea University Guro Hospital, Seoul, Republic of Korea
- Chae, Shung ChullKyungpook National University Hospital, Daegu, Republic of Korea
- Kim, Chong JinKyung Hee University Hospital at Gangdong, Seoul, Republic of Korea
- 차광수Pusan National University Hospital, Busan, Republic of Korea
- Park, Jong SeonYeungnam University Hospital, Daegu, Republic of Korea
- Yoon, Jung HanYonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea
- Chae, Jei KeonChunbuk National University Hospital, Jeonju, Republic of Korea
- Joo, Seung JaeJeju National University Hospital, Jeju, Republic of Korea
- Choi, Dong JuSeoul National University Bundang Hospital, Seongnam, Republic of Korea
- Hur, Seung HoKeimyung University Dongsan Medical Center, Daegu, Republic of Korea
- Seong, In WhanChungnam National University Hospital, Daejeon, Republic of Korea
- Cho, Myeong ChanChungbuk National University Hospital, Cheongju, Republic of Korea
- Kim, Doo IlInje University Haeundae Paik Hospital, Busan, Republic of Korea
- Oh, Seok KyuWonkwang University Hospital, Iksan, Republic of Korea
- Ahn, Tae HoonGachon University Gil Medical Center, Incheon, Republic of Korea
- Hwang, Jin YongKyungsang National University Hospital, Jinju, Republic of Korea
초록
Background: The optimal duration of dual antiplatelet therapy (DAPT) after acute coronary syndrome remains uncertain. This study investigated the benefit of DAPT beyond 12 months after drug-eluting stents (DES) for acute myocardial infarction (MI). Methods: From Korea Acute Myocardial Infarction Registry-National Institute of Health database, 6199 patients treated with DAPT for 12 months after DES (second-generation DES 98%) without ischemic or bleeding events were analyzed. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE), a composite of death from any cause, MI, or ischemic stroke during the period from 12 to 24 months. Results: After adjustment using inverse probability of treatment weighting, patients who received DAPT beyond 12 months (n = 4795), compared to patients treated with 12-month DAPT (n = 1404), had a similar incidence of MACCE (1.3% vs. 1.0%, HR: 1.32, 95% CI: 0.71-2.45, p = 0.378). The 2 groups did not differ significantly in the rates of death (0.1% vs. 0.1%), MI (0.8% vs.0.6%), stent thrombosis (0.1% vs. 0.2%), ischemic stroke (0.4% vs. 0.2%), and major bleeding (0.1% vs. 0.1%). The rate of net adverse clinical events was 1.4% with DAPT beyond 12 months and 1.1% with 12-month DAPT (p = 0.466). Conclusions: DAPT beyond 12 months, as compared with 12-month DAPT, in real-world patients with acute MI treated predominantly with second-generation DES did not reduce the risk of MACCE. The rates of major bleeding and net adverse clinical events did not differ significantly between the 2 treatments. (C) 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
키워드
Antiplatelet agentsDrug-eluting stentsMyocardial infarctionFOCUSED UPDATEIMPLANTATIONCLOPIDOGRELDURATIONTRIALMETAANALYSISVALIDATIONTICAGRELORGUIDELINEEFFICACY
식별자
- Scopus EID
- 2-s2.0-85072586455
- WoS UID
- 000527373800011



로그인
연구물 목록으로